Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Signature Bioscience Seeks San Francisco Headquarters
Signature Bioscience is seeking between 70,000-sf and 80,000-sf in San Francisco for its headquarters, currently housed in 27,000-sf in Hayward and 28,000-sf in Richmond. The Richmond facility may be retained in the relocation. Draws for a San Francisco headquarters include the new UC San Francisco Mission Bay campus and its planned life science campus. Catellus Development Corp., developer of the life science facility, has estimated completion of the 155,000-sf building in 2002, not timely for Signature's move.
University of Maryland Develops CARB I & II
The University of Maryland's Shady Grove campus in Rockville is planning to begin expansion of its Center for Advanced Research in Biotechnology (CARB) in March 2002. The current 88,000-sf facility will be joined by another four-story, 140,000-sf building dubbed CARB II. The $38 million project is designed by architects Burt Kosar Rittelmann Associates of Pennsylvania, with construction company Barton Malow of Southfield, Mich., as general contractor. The facility is slated for completion in 2004.
Texas A&M University at Corpus Christi Plans New Facilities
Texas A&M University at Corpus Christ plans to develop a new classroom and lab facility with $34 million in funds, part of a $1 billion revenue bond initiative for new projects in Texas. The Hart Research Center for Gulf of Mexico Studies is also slated for development with the grant. The center brings the perspectives of bio-diversity and economic sustainability to bear on issues relative to the Gulf of Mexico.
New Syngenta Office in RTP
Syngenta, a biotechnology firm based in Basel, Switz., plans to begin construction at its RTP campus on a new 24,682-sf facility to house offices and a conference center. Architect for the building is Cline Design Associates; the general contractor is Shelco Inc. Syngenta works in the field of agricultural applications of biotechnology.
Ambion Seeks Approval For New Manufacturing Lab
Austin-based Ambion Inc.'s Diagnostic RNA unit has built a new manufacturing lab and is seeking approval by the U.S. Food and Drug Administration to begin manufacturing products. Shifting its focus to the molecular pathology market, Ambion began the development in October 2000. The facility also houses space for devising disease test kit formulas.